Cytokinetics reported $-80550000 in Operating Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -113.02M 68.36M
Acorda Therapeutics ACOR:US $ -16.7M 5.14M
Amgen AMGN:US $ 2500M 196M
Arca Biopharma ABIO:US $ -5680000 1.58M
Bayer BAYN:GR 4.21B 2.19B
Biogen BIIB:US $ 610.7M 23.6M
Brainstorm Cell Therapeutics BCLI:US $ -5475000 737K
Bristol Myers Squibb BMY:US $ 2553M 90M
Capricor Therapeutics CAPR:US $ -7.83M 1.44M
Cytokinetics CYTK:US $ -80.55M 58.85M
Eisai 4523:JP Y -20803M 34451M
Eli Lilly And LLY:US $ 2404.3M 487.1M
Exelixis EXEL:US $ 83.24M 33.4M
Genocea Biosciences GNCA:US $ -15.77M 2.36M
Geron GERN:US $ -28.68M 2.31M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Intra Cellular Therapies ITCI:US $ -72.66M 13.34M
IONIS PHARMACEUT IONS:US $ -57.5M 278.11M
Ligand Pharmaceuticals LGND:US $ -7.81M 20.54M
Merk MRK:US $ 5569M 1994M
Novartis NOVN:VX 2.85B 290M
Pfizer PFE:US $ 9873M 5297M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M